Alerts will be sent to your verified email
Verify Email
MOREPENLAB
|
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Global DMFs filed
|
211.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.87 % | 1.01 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
13.43 % | 8.9 % | -10.41 % |
|
5yr average Equity Multiplier
|
1.68 | 1.42 | 1.99 |
|
5yr Average Asset Turnover Ratio
|
1.29 | 0.99 | 0.54 |
|
5yr Avg Net Profit Margin
|
5.93 % | 6.28 % | -7.28 % |
|
Price to Book
|
1.94 | 1.42 | 2.12 |
|
P/E
|
23.57 | 21.42 | 414.44 |
|
5yr Avg Cash Conversion Cycle
|
12.78 Days | 37.81 Days | 28.67 Days |
|
Inventory Days
|
54.64 Days | 65.55 Days | 111.94 Days |
|
Days Receivable
|
65.45 Days | 86.45 Days | 95.97 Days |
|
Days Payable
|
96.29 Days | 100.1 Days | 146.85 Days |
|
5yr Average Interest Coverage Ratio
|
39.11 | 15.8 | 0.25 |
|
5yr Avg ROCE
|
15.77 % | 12.63 % | 2.1 % |
|
5yr Avg Operating Profit Margin
|
8.68 % | 10.64 % | 9.63 % |
|
5 yr average Debt to Equity
|
0.04 | 0.04 | 0.7 |
|
5yr CAGR Net Profit
|
3.98 % | -9.63 % | -69.98 % |
|
5yr Average Return on Assets
|
7.67 % | 6.27 % | -3.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.65 % | 52.62 % | 42.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 35.32 % |
|
Change in Promoter Holding (3 Yrs)
|
-2.57 % | 8.93 % | 1.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -1.37 % |
|
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|